[PCRX] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[PCRX] Pacira BioSciences, Inc.
Announcement Date
02-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- 231.87%
YoY- 29.62%
Quarter Report
PCRX's Result
PCRX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 167,117 181,244 163,926 169,467 160,341 171,955 167,466 -0.13%
PBT 13,640 33,720 16,601 37,854 -26,474 -18,068 2,069 251.18%
Tax 4,661 8,850 5,743 12,091 -6,938 -7,966 2,762 41.69%
NP 8,979 24,870 10,858 25,763 -19,536 -10,102 -693 -
Tax Rate -34.17% -26.25% -34.59% -31.94% - - -133.49% -
Total Cost 158,138 156,374 153,068 143,704 179,877 182,057 168,159 -4.00%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin 5.37 13.72 6.62 15.20 -12.18 -5.87 -0.41 -
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS 0.19 0.54 0.23 0.56 -0.43 -0.22 -0.02 -
EPS Diluted 0.19 0.48 0.23 0.49 -0.43 -0.22 -0.02 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.